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Endocannabinoid signaling is considered to sup-
press excessive excitability of neural circuits and to
protect the brain from seizures. However, the precise
mechanisms of this effect are poorly understood.
Here, we report that 2-arachidonoylglycerol (2-AG),
one of the two major endocannabinoids, is crucial
for suppressing seizures. We found that kainate-
induced seizures in mice lacking the 2-AG synthesiz-
ing enzyme, diacylglycerol lipase a, were much more
severe compared with those in cannabinoid CB1 re-
ceptor knockout mice and were comparable to those
in mice lacking both CB1- and CB2-receptor-medi-
ated signaling. In the dentate gyrus, 2-AG sup-
pressed excitatory input around the inner andmiddle
molecular layers through CB1 and presumably CB2
receptors, respectively. This 2-AG-mediated sup-
pression contributed to decreased granule cell excit-
ability and the dampening of seizures. Furthermore,
lack of 2-AG signaling enhanced kindling epilepto-
genesis and spontaneous seizures after kainate-
induced status epilepticus. These results highlight
critical roles of 2-AG signaling in the suppression of
epileptic seizures.INTRODUCTION
Epilepsy is a common and disabling neurological disorder with
multiple etiologies that affects about 0.8% of the world’s popu-
lation (Moshe´ et al., 2015). Some forms of epilepsy, such as
mesial temporal lobe epilepsy, are highly resistant to medication
(Stephen et al., 2001); therefore, there is a continuous need for
the development of new anti-epileptic drugs. Enhancement of
GABAergic inhibition and suppression of glutamatergic excita-
tion, voltage-dependent Na+ channels, or voltage-gated Ca2+
channels are the major modes of action of currently used anti-
epileptic drugs (Rogawski and Lo¨scher, 2004). However, the en-Cell R
This is an open access article unddocannabinoid system has emerged as a novel target for anti-
epileptic drugs (Porter and Jacobson, 2013).
Endocannabinoids are produced and released from postsyn-
aptic neurons in activity-dependent manners, act retrogradely
on cannabinoid CB1 receptors in presynaptic terminals, and sup-
press neurotransmitter release (Kano et al., 2009; Ohno-Sho-
saku and Kano, 2014). CB1 receptors and the molecules for en-
docannabinoid synthesis are present throughout the nervous
system; therefore, endocannabinoid-mediated retrograde sup-
pression is considered to be a ubiquitous and important form
of activity-dependent synaptic modulation. In line with this
notion, endocannabinoid signaling has been shown to play
crucial roles in a variety of brain functions including learning
and memory (Kano et al., 2009), anxiety (Lafene^tre et al.,
2007), addiction (Sidhpura and Parsons, 2011), pain modulation
(Nadal et al., 2013), feeding behavior (Silvestri and Di Marzo,
2013), and neuroprotection (Sa´nchez and Garcı´a-Merino,
2012). Above all, control of excessive excitability and prevention
of epileptic seizures appear to be important functions of the en-
docannabinoid system (Katona and Freund, 2008; Soltesz et al.,
2015). Indeed, many previous studies demonstrate that CB1-re-
ceptor-mediated endocannabinoid signaling has suppressive
effects on seizures (Marsicano et al., 2003; Monory et al.,
2006). However, it remains to be determined which of the two
major endocannabinoids, 2-arachidonoylglycerol (2-AG) (Me-
choulam et al., 1995; Sugiura et al., 1995) or anandamide (De-
vane et al., 1992), mediates the suppression of seizures. It is
also not known how endocannabinoid signaling suppresses sei-
zures. Inhibition of glutamate release is a likely mechanism, but
there are no in vivo physiological studies that directly support
this notion. Another important but unsolved issue is whether en-
docannabinoids also affect the development of epileptic focus,
also termed epileptogenesis. Suppression, but not enhance-
ment, of CB1-receptor-mediated endocannabinoid signaling
was shown to significantly increase the seizure threshold in a
febrile seizuremodel (Chen et al., 2007). However, a recent study
reported that blockade of 2-AG hydrolysis by JZL184 retarded
the development of amygdala kindling epileptogenesis (von
R€uden et al., 2015a).
In the present study, we tackled the issues whether and how
2-AG signaling prevents seizures and epileptogenesis. Oureports 16, 1405–1415, August 2, 2016 ª 2016 The Author(s). 1405
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1. Kainate-Induced Acute Seizures in Several Mouse Models
with Deleted/Blocked 2-Arachidonoylglycerol Signaling
(A) Latency to generalized tonic-clonic seizure (GTCS) after intraperitoneal
injection of kainate (KA, 30 mg/kg, i.p.). Sixty minutes before the KA injection,
wild-type (WT) mice, diacylglycerol lipase a knockout (DGLa KO) mice, CB1
knockout (CB1 KO) mice, and their WT littermates had undergone one of the
following drug treatments: the CB1 antagonist AM251 (20 mg/kg, i.p.) alone,
the CB2 antagonist AM630 (2 mg/kg, i.p) alone, combined AM251 and AM630,
or vehicle. The number inside each column represents the number of mice that
developed seizures. Error bars attached to individual columns represent ±
SEM. *p < 0.05, **p < 0.01, ***p < 0.001 by Welch’s t test.
(B) Mortality during 20 min after KA injection. The number inside each column
shows ([the number of mice that died] / [the number of mice that developed
seizures]). !p < 0.05, !!p < 0.01, !!!p < 0.001, by Fisher’s exact test.results highlight the importance of 2-AG signaling in the dentate
gyrus for the suppression of seizures and epileptogenesis and
suggest that enhancement of 2-AG signalingmay be a promising
strategy for the development of new anti-epileptic drugs.
RESULTS
2-AG Signaling Is Crucial for the Suppression of Seizure
Generation
We first asked whether 2-AG has suppressive effects on seizure
generation in the non-epileptic mouse brain. We usedmice lack-1406 Cell Reports 16, 1405–1415, August 2, 2016ing diacylglycerol lipase (DGL) a (Tanimura et al., 2010), one of
the two 2-AG synthesizing enzymes, and CB1 knockout (KO)
mice (Figure S1). We injected DGLa KO mice and wild-type
(WT) littermates with kainate (KA) (30 mg/kg, i.p.) and estimated
the severity of seizures. Latency from the KA injection to the
onset of generalized tonic-clonic seizure (GTCS) was signifi-
cantly shorter in DGLa KO mice than in WT littermates (t test,
t = 8.26, p < 0.0001; Figure 1A). All DGLa KO mice died within
20 min after the initiation of seizures, whereas only 14.3% of
WT littermates died (Fisher’s exact test, p = 0.00466; Figure 1B).
CB1 KOmice also showed significantly shorter latency to seizure
onset after KA injection compared with their WT littermates
(t test, t = 2.54, p = 0.0225; Figure 1A), but both genotypes ex-
hibited similar mortality rates (30% for CB1 KO mice versus
14.3% for WT littermates, Fisher’s exact test, p = 0.603; Fig-
ure 1B). Notably, the latency was shorter (t test, t = 3.78, p =
0.00182; Figure 1A) and the mortality was higher (100% versus
30%, Fisher’s exact test, p = 0.00982; Figure 1B) in DGLa KO
than in CB1 KO mice. WT mice treated with a CB1 antagonist,
AM251 (20 mg/kg, i.p.), also showed significantly shorter latency
compared with vehicle-treated WT mice (t test, t = 3.51, p =
0.00383; Figure 1A). The latency was significantly longer (t test,
t = 3.02, p = 0.0108; Figure 1A) and the mortality rate lower
(42.9%, Fisher’s exact test, p = 0.0699; Figure 1B) in AM251-
treated mice than in DGLa KO mice. These results suggest
that the suppressive effect of 2-AG on KA-induced seizures
involves not only CB1-mediated processes but also other mech-
anisms independent of CB1.
While CB1 is widely expressed in the CNS, the other cannabi-
noid receptor, CB2, is mainly expressed in the immune system
(Kano et al., 2009). However, accumulating evidence suggests
that CB2 receptors are functional in the CNS (Li and Kim, 2016;
Stempel et al., 2016). A recent study reported the antiepileptic ef-
fect of CB2 antagonist, AM630, when co-administered with
cannabinoid receptor agonist, WIN 55,212-2 (Rizzo et al.,
2014). However, the antagonist alone did not affect seizures
evoked in the non-epileptic brain (Rizzo et al., 2014). Because
2-AG is known to activate CB2 receptors (Van Sickle et al.,
2005), we examined the possibility that CB2 receptors contribute
to the suppression of seizures in our experimental conditions.
We treated CB1 KO mice with a CB2 antagonist (AM630,
2 mg/kg, i.p.) and injected these mice with KA. The latency to
seizure onset was significantly shorter (t test, t = 2.59, p =
0.0206; Figure 1A) and the mortality rate was significantly higher
in CB1 KOmice treated with AM630 than in CB1 KOmice treated
with vehicle (85.7% versus 30%, Fisher’s exact test, p = 0.0498;
Figure 1B). Similarly, the latency to seizure onset of WT mice
treated with AM251+AM630 was significantly shorter than that
of WT mice treated with AM251 alone (t test, t = 2.75, p =
0.0177; Figure 1A). All of the AM251+AM630-treated WT mice
died within 20 min (mortality: 100%, Fisher’s exact test, p =
0.00140 versus WT mice; Figure 1B). Importantly, however, WT
mice treated with AM630 alone had a latency and mortality
rate that were comparable to those of vehicle-treated WT mice
(t test, t = 0.223, p = 0.831 for latency, 50%, Fisher’s exact
test, p = 0.245 for mortality; Figures 1A and 1B). These results
suggest that 2-AG suppresses generation of seizures primarily
through CB1 and secondarily through CB2 receptors.
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Figure 2. Suppression of Epileptic Afterdischarge in the Dentate
Hilus by 2-Arachidonoylglycerol Signaling through CB1 and Pre-
sumably CB2 Receptors
(A) Example traces of afterdischarges recorded in the dentate hilus ofWTmice,
DGLa KO mice, WT mice treated with AM251 (WT: AM251), WT mice treatedIn line with these results, recent reports show the localization
of CB2 receptors in the hippocampal CA1, CA3 and the dentate
gyrus (Li and Kim, 2015; Stempel et al., 2016). Using real-time
PCR, we quantified the level of mRNA for CB2 receptors in the
hippocampus to be 0.00109% ± 0.000487% of that of glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH, n = 10), which is
in the same order of magnitude as that described in the report of
Li and Kim (2015). Because the severity of KA-induced seizures
was very similar between genetic deletion and pharmacological
blockade of CB1 receptors, we hereafter used AM251 treatment
to investigate the role of CB1-receptor-mediated processes in
seizure suppression.
2-AG Suppresses Dentate Afterdischarges through CB1
and Presumably CB2 Receptors
CB1-mediated protection against KA-induced seizures depends
on CB1 receptors around the dentate gyrus (Monory et al.,
2006). This suggests that CB1-receptor-mediated signaling
may antagonize epileptic discharge in the dentate gyrus. To
examine this possibility, we recorded local field potentials
(LFPs) in the dentate gyrus of anesthetized mice and induced
afterdischarges by perforant path stimulation. Burst stimuli
induced significantly longer afterdischarges in DGLa KO mice
compared with WT mice (Mann-Whitney U test, U = 1, p <
0.01; Figures 2A and 2B). Minimal stimulus intensity required
to induce afterdischarges was significantly lower in DGLa
KO mice compared with WT littermates (t test, t = 2.39, p =
0.0306; Figure 2C). Prior treatment of WT mice with AM251 or
AM251+AM630 significantly increased the duration of afterdi-
scharges (Mann-Whitney U test, U = 10, p < 0.05, and U = 6,
p < 0.01, respectively; Figures 2A and 2B). In contrast to the
duration, AM251 or AM251+AM630 treatment did not affect
the minimal stimulus intensity (Figure 2C). There was no signif-
icant difference in these two parameters between AM251 and
AM251+AM630 treatment (Figures 2A–2C). Importantly, treat-
ment with AM251+AM630 had no additive effect in DGLa
KO mice (Figures 2A–2C; DGLa KO versus DGLa KO:
AM251+AM630). Furthermore, the duration of afterdischarges
and the minimal stimulus intensity were comparable among
DGLa KO mice, WT mice treated with AM251 alone, and WT
mice treated with AM251+AM630 (Figures 2A–2C). These
results suggest that the effect of AM251 and/or AM630 is
occluded in DGLa KO mice, and that 2-AG decreases thewith AM251 and AM630 (WT: AM251+AM630) and DGLa KO mice treated
with AM251 and AM630 (DGLa KO: AM251+AM630). The green bar above
the recordings indicates the period during which the perforant path was
stimulated.
(B and C) Summary data for the duration of afterdischarge (B) and for the
minimal stimulus intensity required to induce afterdischarges (C). The number
inside each column represents the number of mice examined.
(D) Example traces of single burst discharge observed during afterdischarges
in the dentate hilus of WT or DGLa KO mice that underwent one of the indi-
cated treatments.
(E and F) Summary data for the duration of single burst discharge (E) and for the
interspike interval (F). The number inside each column represents the number
of burst discharges (E) and the number of interspike intervals (F).
Error bars attached to individual columns represent ± SEM +p < 0.05, ++p <
0.01, +++p < 0.001 by Mann-Whitney U test. **p < 0.01 by Welch’s t test.
Cell Reports 16, 1405–1415, August 2, 2016 1407
duration of afterdischarges induced by perforant path stimula-
tion mainly through CB1 receptors.
In WT mice, a burst of epileptic discharge occurred only once
in most cases (Figure 2A). In contrast, bursts of epileptic
discharge often repeated in DGLa KO mice (Figure 2A). The
duration of single epileptic burst discharge was significantly
longer in DGLa KO mice than in WT littermates (Mann-Whitney
U test, Z = 2.13, p = 0.0329; Figures 2D and 2E). The duration
in AM251-treated WT mice was also significantly longer than
that in vehicle-treated mice (Mann-Whitney U test, Z = 3.31,
p = 0.000922; Figures 2D and 2E). Furthermore, the duration in
WT mice treated with AM251+AM630 was significantly longer
than that in WT mice treated with AM251 alone (Mann-Whitney
U test, Z = 2.61, p = 0.0448; Figures 2D and 2E). To further
assess the extent of hyperexcitability in the dentate gyrus, we
measured the interspike interval (ISI) during epileptic burst dis-
charges. The ISI was significantly shorter in DGLa KO mice
than in WT littermates (Mann-Whitney U test, Z = 2.85, p =
0.00441; Figures 2D and 2F). Treatment with AM251+AM630
induced a significantly shorter ISI in WT mice than with AM251
treatment alone (Mann-Whitney U test, Z = 5.09, p < 0.00001;
Figures 2D and 2F). However, treatment with AM251 alone
caused no significant effect on the ISI when compared with
vehicle treatment (Mann-Whitney U test, Z = 1.41, p = 0.159;
Figures 2D and 2F). Taken together, these results suggest that
2-AG suppresses perforant path stimulation-induced epileptic
burst discharges in the dentate gyrus through both CB1 and
CB2 receptors.
Optogenetic Inhibition of Dentate Output Suppresses
Afterdischarges
We next checked whether neural activity in the dentate gyrus
was necessary for sustaining seizure activities in vivo. It is
possible that afterdischarges recorded in the dentate gyrus
are driven by other brain regions such as the CA1 (Bragin
et al., 1997). To suppress dentate neural activity optogenetically,
we injected adenoassociated viral (AAV) vectors for the expres-
sion of Archaerhodopsin T (ArchT) under control of the CaMKII
promoter (AAV1-CaMKII-ArchT/GFP) bilaterally into the dentate
gyrus of DGLa KOmice (Figure S2A) or into the right dentate gy-
rus of WT mice (Figure S2E). Four weeks after the injection, we
successfully suppressed the population spike in the dorsal den-
tate gyrus by optogenetics (Figures S2B and S2F). The optoge-
netic suppression of the bilateral dorsal dentate gyrus during
afterdischarges significantly decreased the durations of afterdi-
scharges in DGLa KO mice (Mann-Whitney U test, Z = 2.87,
p = 0.00413; Figures S2C and S2D). Similarly, optogenetic sup-
pression in AM251-treated WT mice significantly decreased the
number of burst discharges (Mann-Whitney U test, Z = 2.54,
p = 0.0110; Figures S2G and S2H). These results suggest
that excessive neural activity in the dentate gyrus is necessary
for long-lasting afterdischarges evoked by perforant path
stimulation.
Increased Synaptic Input during Afterdischarges in the
Dentate Gyrus of DGLa KO Mice
Long-lasting afterdischarges in mice lacking 2-AG signaling
could be ascribed to strong depolarization and heightened activ-1408 Cell Reports 16, 1405–1415, August 2, 2016ity of granule cells by burst stimulation to the perforant path.
To test this possibility, we made in vivo whole-cell recordings
from granule cells and measured their membrane potentials in
AM251+AM630-treated WT mice (Figure S3A). During burst
stimulation of the perforant path, granule cells became gradually
depolarized and their membrane potentials reached plateau
levels (Figure S3B). After burst stimulation, membrane potentials
gradually returned to the pre-stimulation level (Figure S3C).
There was no significant correlation between the minimal stim-
ulus intensity required to induce afterdischarges and the mem-
brane potential at the end of burst stimulation (Pearson correla-
tion coefficient, r = 0.357, p = 0.175) nor between the membrane
potential at the end of burst stimulation and the number of burst
synaptic input (Pearson correlation coefficient, r = 0.257, p =
0.336; Figure S3D). However, we found that the amplitude of
the first excitatory postsynaptic potential (termed ‘‘epileptic syn-
aptic input’’; Figure S3C) positively correlated with the number of
burst synaptic input (Pearson correlation coefficient, r = 0.717,
p = 0.00179; Figure S3E). These results suggest that the strong
excitatory synaptic input to granule cells during burst discharges
is a cause of long-lasting afterdischarges in DGLa KO mice.
To examine whether synaptic inputs to dentate granule cells
are increased in DGLa KO mice, we recorded LFPs of the den-
tate gyrus using a 16 channel silicon probe and calculated cur-
rent source density (CSD). The CSD analysis enables us to sepa-
rately evaluate the synaptic input in each layer of the dentate
gyrus. We found that sink currents in the inner molecular layer
(IML) of DGLa KO mice were significantly larger than those of
WT littermates during burst discharges (Mann-Whitney U test,
Z = 3.88, p = 0.000104; Figures 3A and 3B). WT mice treated
with AM251 alone or with AM251+AM630 also had significantly
larger sink currents in the IML than vehicle-treated mice
(Mann-Whitney U test, Z = 3.18, p = 0.00146 for AM251-treated
mice, Z = 2.76, p = 0.00576 for AM251+AM630-treated mice;
Figure 3B). The strength of excitatory synaptic input in the IML
was comparable among the three groups (Figure 3B), suggesting
that CB1-mediated mechanisms are essential for the suppres-
sion of the IML input during afterdischarges. Because CB1 re-
ceptors are strongly expressed at mossy cell terminals in the
IML (Uchigashima et al., 2011), changes in excitatory synaptic in-
puts from mossy cells to granule cells are presumably the major
cause of increased excitatory synaptic input in the IML.
In the MML, sink currents of DGLa KO mice were significantly
larger than those of WT littermates (Mann-Whitney U test,
Z = 2.22, p = 0.0263; Figures 3A and 3C). Likewise, sink currents
in the MML of AM251+AM630-treated WT mice were signifi-
cantly larger than those of vehicle-treated control mice (Mann-
Whitney U test, Z = 1.96, p = 0.0308; Figure 3C). Unexpectedly,
MML sink currents of AM251-treated mice were comparable to
those of vehicle-treated control mice and were significantly
smaller than those of AM251+AM630-treated WT mice (Mann-
Whitney U test, Z = 2.25, p = 0.0242; Figure 3C). These results
suggest that 2-AG suppresses excitatory synaptic currents in
the MML presumably through CB2 receptors. Since excitatory
synapses in the MML originate from the perforant path, these re-
sults suggest that excitatory synaptic inputs from the entorhinal
cortex are regulated by 2-AG through CB2-dependent mecha-
nisms during seizures.
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Figure 3. Current Source Density Analysis of Local Field Potentials
in the Dentate Gyrus Induced by Perforant Path Stimulation
(A) Color maps showing current source density (CSD) in the dentate gyrus after
single perforant path stimulation (PP stim) and during afterdischarges in WT
(upper panel) and DGLa KOmice (lower panel). The areas of the CSDmap that
correspond to the middle molecular layer (MML) and the inner molecular layer
(IML) are surrounded with black lines. Current sink (blue) after perforant path
stimulation indicates inward current at the MML. Sections of the local field
potential (LFP) traces shaded by gray rectangles correspond to the period
indicated with gray bars over the CSD maps during afterdischarges.
(B and C) Magnitudes of sink currents during single burst discharge in the IML
(B) and in theMML (C). The number inside each column represents the number
of burst discharges.
Error bars represent means ± SEM +p < 0.05, ++p < 0.01, +++p < 0.001 by
Mann-Whitney U test.Optogenetic Activation of Mossy Cell Terminals
Promotes Afterdischarges
To confirm the promoting effect of mossy cells on dentate after-
discharges, we selectively stimulated mossy cell axons during
afterdischarges by optogenetics. Mossy cells are known to proj-
ect to the contralateral IML. Therefore, injection of AAV contain-
ing channelrhodopsin/wide receiver (Wang et al., 2009) (AAV2-
CAGGS-ChRWR/Venus) into the right dentate gyrus resulted in
the expression of ChRWR in nerve terminals in the IML of the
left dentate gyrus (Figure 4A). We confirmed that optogenetic
stimulation of ChRWR-expressing cells on the right side induced
current sink around the IML of the left dentate gyrus (Figure 4B).
Then, in WT mice, we optogenetically stimulated mossy cell
axons in the left dentate gyrus for 10 s after electrical stimulation
of the perforant path. We found a significant increase in the num-
ber of burst discharges by optogenetic stimulation (one-way
repeated-measures ANOVA, p = 0.0362; Figures 4C and 4D),
suggesting that the activation of mossy cells can promote sei-
zures. Taken together, these results suggest that dentate
granule cells in DGLaKOmice are hyperexcited by the increased
excitatory synaptic input from mossy cells and the entorhinal
cortex, leading to long-lasting seizures by excess activation of
mossy cells through recurrent collaterals.
2-AG Suppresses Epileptogenesis in the Perforant Path
Kindling Model
Next, we examined whether 2-AG signaling influences epilepto-
genesis in mice using the perforant path kindling model (Maru
and Goddard, 1987). Stimulation and recording electrodes
were chronically implanted, and afterdischarges were induced
in the dentate gyrus. We found that DGLa KO mice exhibited a
significantly longer first afterdischarge in the dentate gyrus
than WT littermates (Mann-Whitney U test, U = 27, p < 0.05; Fig-
ures 5A and 5B). The stimulus intensity required to induce the
first afterdischarge was significantly lower in DGLa KO mice
than in WT littermates (t test, t = 2.20, p = 0.0435; Figure 5C).
As kindling proceeded, the evoked seizures became more se-
vere (Figure 5D). The numbers of kindling stimuli required to
develop the first class V seizures (Racine, 1972) (t test,
t = 2.66, p = 0.0206; Figure 5E), and three consecutive class V
seizures (t test, t = 2.61, p = 0.0230; Figure 5E) were both signif-
icantly smaller in DGLa KO mice than in WT littermates. Twenty-
five percent (two of eight) of DGLa KO mice developed sponta-
neous seizures, whereas no WT littermates did (Figure 5F).
Waveforms of burst discharge during spontaneous seizures in
awake DGLa KO mice were similar to those observed during
evoked afterdischarges under anesthesia (Figure 5G), suggest-
ing that identical neural circuits were involved.
We also investigated the effects of CB1 and CB2 receptor an-
tagonists on dentate afterdischarges and kindling epileptogene-
sis. Administration of either AM251 or AM630 alone did not affect
the duration of the first afterdischarges or the minimal stimulus
intensity (Figures 6A and 6C). However, co-administration of
AM251 and AM630 to WT mice significantly increased the dura-
tion of the first afterdischarge compared with that after vehicle
treatment (Mann-Whitney U test, Z = 2.49, p = 0.0129; Figure 6A).
Because the duration of afterdischarges varied greatly at
the initial stage of kindling, we measured the mean durationCell Reports 16, 1405–1415, August 2, 2016 1409
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Figure 4. Optogenetic Activation of Mossy Cell Axons Enhances
Epileptic Discharges in the Dentate Gyrus In Vivo
(A) Expression of channelrhodopsin/wide receiver (ChRWR)-Venus in the right
(R) dentate gyrus (DG) and the left (L) dentate IML (arrow heads) 4 weeks after
injection of the AAV carrying cDNAs for ChRWR and Venus. Scale bar, 500 mm.
(B) CSD map of the left dentate gyrus after stimulation of the left medial per-
forant path (MPP stim, left panel) and after optogenetic stimulation of the right
dentate gyrus (right panel). The upward arrow and the blue bar, respectively,
indicate the timing of left perforant path stimulation and the period of blue light
stimulation to the right dentate gyrus. MML, IML, and granule cell layer (GL) are
separated by dotted lines.
(C) Example traces of afterdischarges induced by perforant path stimulation
recorded in the left dentate hilus with (blue) or without (black) blue light stim-
ulation. Burst stimulation was applied to the left perforant path and 50 ms light
stimulation at 10 Hz (blue dotted line) was applied to the left IML.
(D) The average number of burst discharges in five successive afterdischarges
with (second and fourth trials) or without (first, third, and fifth trials) light
stimulation. Colored lines represent data from individual mice, and the black
line shows the mean with error bars representing ± SEM. *p < 0.05 by one-way
analysis of variance.
1410 Cell Reports 16, 1405–1415, August 2, 2016of the five initial afterdischarges. Daily administration of
AM251+AM630 to WT mice significantly increased the mean
duration of the initial five afterdischarges compared with that
produced by vehicle treatment (Mann-Whitney U test, Z = 3.70,
p = 0.000219; Figure 6B). Treatment with AM630 but not with
AM251 significantly increased the mean duration of the initial
five afterdischarges (Mann-Whitney U test, Z = 2.20, p =
0.0276; Figure 6B). The number of kindling stimuli required to
induce three consecutive class V seizures was significantly
smaller in mice treated with AM251+AM630 compared with
vehicle-treated mice (Mann-Whitney U test, Z = 1.96, p =
0.0497; Figure 6D). However, treatment with either AM251 or
AM630 alone had no effect on the number of kindling stimuli
(Figure 6D). Taken together, these results suggest that 2-AG
suppresses epileptogenesis in the hippocampus through CB1
and CB2-mediated mechanisms.
Augmentation of 2-AG Levels Suppresses Seizure
Generation, Epileptogenesis, and Spontaneous
Seizures
Finally, we investigated whether enhancement of 2-AG signaling
can ameliorate seizure generation, epileptogenesis, or the
occurrence of spontaneous seizures. To elevate 2-AG levels in
brain tissues, we used JZL184, a specific inhibitor of the major
2-AG hydrolyzing enzyme, monoacylglycerol lipase. We found
that administration of JZL184 (40 mg/kg, i.p.) to WT mice signif-
icantly decreased the occurrence of GTCS during 60 min after
KA injection (46.7% for vehicle versus 0% for JZL184, Fisher’s
exact test, p = 0.0225), clearly indicating that augmentation of
2-AG levels suppresses seizure generation.
We then examined the effect of JZL184 treatment on epilepto-
genesis in the perforant path kindling model. We found that
JZL184 treatment in WT mice significantly increased the stim-
ulus intensity required to induce the first afterdischarges and
decreased the first afterdischarge duration compared with
vehicle treatment (stimulus intensity: Mann-Whitney U test,
Z = 2.58, p = 0.00992; afterdischarge duration: Mann-Whitney
U test, Z = 2.31, p = 0.0210; Figures 6A and 6C). The treatment
also decreased the mean duration of the initial five afterdi-
scharges (Mann-Whitney U test, Z = 2.57, p = 0.0101; Figure 6B).
The number of kindling stimuli required to achieve three consec-
utive class V seizures was significantly larger in JZL184-treated
WT mice than in vehicle-treated WT mice (Mann-Whitney U
test, Z = 2.44, p = 0.0146; Figure 6D). These results indicate
that augmentation of 2-AG levels suppresses epileptogenesis.
We then askedwhether JZL184 treatment can suppress spon-
taneous seizures by using a KA-induced chronic seizure model
(Bouilleret et al., 1999). KA was injected into the right dentate
gyrus of 8-week-old mice. Two weeks later, daily injection of
JZL184 (4 mg/kg, i.p.), AM251 (20 mg/kg, i.p.), or vehicle was
started and continued for 10 days. From the second day of
drug treatment, the number of spontaneous seizures that
occurred during 6 hr per day were counted for 9 consecutive
days (Figure 7A). We found that JZL184 treatment significantly
decreased the number of spontaneous seizures compared
with vehicle treatment (t test, t = 2.11, p = 0.0491; Figures 7B
and 7C). In contrast to JZL184, AM251 treatment significantly
increased the number of spontaneous seizures (t test, t = 2.91,
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Figure 5. Enhanced Epileptogenesis in DGLa KO Mice in the Per-
forant Path Kindling Model
(A) Example traces of the first afterdischarges recorded in the dentate hilus of
freely moving DGLa KO mice (red) and WT littermates (black). The green bar
indicates the period of perforant path stimulation.
(B and C) Summary for the duration of the first afterdischarge (B) and the
stimulus intensity required to induce the first afterdischarges (C) in WT and
DGLa KO mice. The number inside each column represents the number of
mice examined.
(D) Example traces of afterdischarges in the dentate gyrus of a WT mouse in
the first and the 40th kindling trials by perforant path stimulation indicated with
the green bar.
(E) Summary for the number of kindling stimuli required to induce the
first GTCS and three consecutive GTCSs (three GTCSs) in WT and DGLa KO
mice.
Error bars attached to individual columns represent ± SEM (B, C, and E). +p <
0.05 by Mann-Whitney U test (B). *p < 0.05 by Welch’s t test (C and E).p = 0.0179; Figures 7B and 7C) and the mortality rate (3/8 for
AM251-treated mice versus 0/13 for vehicle-treated mice,
Fisher’s exact test, p = 0.0117). Our immunohistochemical anal-
ysis showed that in the dentate gyrus, the expression of CB1 re-
ceptors was significantly decreased (Mann-Whitney U test, Z =
3.87, p = 0.000109; Figures S4A and S4B) and that of DGLa
tended to become weaker (Mann-Whitney U test, Z = 1.85, p =
0.0647; Figures S4A and S4C) 4 weeks after the KA injection.
We also found a significant decrease in the expression of CB1 re-
ceptors (Mann-Whitney U test, Z = 2.42, p = 0.0153; Figures S4A
and S4B) and of DGLa (Mann-Whitney U test, Z = 2.60, p =
0.00937; Figures S4A and S4C) in the hippocampal CA1 area.
Thus, attenuation of 2-AG signaling appears to underlie KA-
induced chronic seizure. Taken together, our results suggest
that augmentation of 2-AG signaling could be an effective ther-
apy for certain forms of epilepsy.
DISCUSSION
2-AG mediates retrograde signals for endocannabinoid-depen-
dent short-term synaptic suppression and long-term depression
(Tanimura et al., 2010). Of two enzymes that can synthesize
2-AG, DGLa and DGLb, DGLa but not DGLb is responsible for
the production of 2-AG in the brain. 2-AG functions as a synaptic
retrograde messenger (Gao et al., 2010; Tanimura et al., 2010)
and is therefore considered to prevent seizure in physiological
conditions by regulating neural circuit activity through retrograde
synaptic suppression. Indeed, genetic deletion of phospholipase
Cb1, the enzyme upstream of DGLa and crucial for 2-AG synthe-
sis (Hashimotodani et al., 2005), resulted in increased seizure
susceptibility in mice (Kim et al., 1997). Furthermore, in patients
with severe mesial temporal lobe epilepsy, decreased 2-AG
signaling in the hippocampus was suggested (Luda´nyi et al.,
2008). Although the level of 2-AG in the brain was reported not
to increase during KA-induced seizure (Marsicano et al., 2003),
in our study, all of the DGLaKOmice died soon after KA injection,
suggesting that 2-AG signaling is crucial for suppressing KA-
induced seizure. We also demonstrated that DGLa KO mice ex-
hibited enhanced kindling epileptogenesis in the dentate gyrus.
Thus, these lines of evidence strongly support 2-AG signaling
to be essential for the suppression of hyperexcitability of dentate
gyrus neural circuits and the prevention of epileptogenesis.
A recent study showed that inhibition of 2-AG catabolism and
elevation of 2-AG levels in postsynaptic neurons caused an
enhancement of GABAA receptor signaling in a cannabinoid-re-
ceptor-independent manner, and that this GABAA receptor
enhancement had a suppressive effect on pentylenetetrazol
(PTZ)-induced seizures (Naydenov et al., 2014). In contrast, we
demonstrated in the present study that there was no additive ef-
fect of the blockade of CB1 and CB2 receptors in DGLa-deleted
mice in perforant path stimulation-induced seizures, suggesting(F) Example traces showing spontaneous seizures recorded in the dentate
gyrus of freely moving DGLa KOmice. A burst discharge indicated by the pink
rectangle is enlarged in (G).
(G) Representative waveform of a single burst discharge observed during
spontaneous seizures in a freely moving DGLa KO mouse (left) and that of
evoked seizures in an anesthetized DGLa KO mouse (right).
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Figure 6. Seizure Generation and Kindling
Epileptogenesis in the Dentate Gyrus of
Freely Moving WT Mice Treated with
AM251, AM630, AM251+AM630, or JZL184
(A–C) Summary bar graphs for the duration
of the first afterdischarge (A), the mean duration
of the initial five afterdischarges (B), and the
stimulus intensity required to induce the first
afterdischarge (C) in WT mice treated with
vehicle, AM251, AM630, AM251+AM630, or
JZL184.
(D) Summary bar graph for the number of
kindling stimuli required to induce three
consecutive GTCS in WT mice treated with
vehicle, AM251, AM630, AM251+AM630, or
JZL184. The number inside each column repre-
sents the number of mice examined.
Error bars attached to individual columns repre-
sent ± SEM +p < 0.05, ++p < 0.01, +++p < 0.001,
by Mann-Whitney U test.that 2-AG acted exclusively on CB1 and CB2 receptors. Previous
studies also suggest that seizures induced by electrical stimula-
tion or by KA injection are regulated strongly by CB1-dependent
mechanisms (Marsicano et al., 2003; Monory et al., 2006; von
R€uden et al., 2015b). One possible explanation for this apparent
discrepancymay be the different stimuli used to induce seizures.
PTZ is thought to suppress GABAA receptor function (Squires
et al., 1984) and therefore 2-AG-induced GABAA receptor
augmentation may potently antagonize the effect of PTZ. In
contrast, KA injection and perforant path stimulation are thought
to enhance excitatory neural circuit activity, and therefore 2-AG-
mediated suppression of excitatory transmission through CB1
receptors seems to be crucial.
In the present study, WT mice with acute blockade of CB1 and
CB2 receptors showed a similar epileptic phenotype to that of
DGLa KO mice. In addition, acute treatment with JZL184 had a
strong suppressive effect on seizure generation and epilepto-
genesis in WT mice, suggesting the importance of acute effects
of 2-AG on cannabinoid receptors. However, deletion of CB1 re-
ceptors decreases adult neurogenesis in the hippocampus (Jin
et al., 2004). Furthermore, lack of CB1 receptor signaling in
GABAergic neurons results in increased numbers of inhibitory
synapses in pyramidal neurons (Berghuis et al., 2007), and the
dendritic spines are decreased in the hippocampus of CB2 KO
mice (Li and Kim, 2016). These changes could potentially affect
the excitability of neural circuits in the hippocampus. Therefore,
we cannot exclude the possibility that compensatory mecha-
nisms may affect the epileptic phenotypes of DGLa KO mice.1412 Cell Reports 16, 1405–1415, August 2, 2016In addition, previous reports suggest a
decrease of neuronal excitability by acute
activation of CB2 receptors located on
postsynaptic neurons (den Boon et al.,
2012; Stempel et al., 2016). Thus, mecha-
nisms other than retrograde suppression
of synaptic transmission might contribute
to the roles of 2-AG in the suppression of
epileptic seizures.In the dentate gyrus, mossy cells form both mono-synaptic
excitatory and di-synaptic inhibitory feedback connections
onto granule cells. Specific ablation of mossy cells by diphtheria
toxin increases the excitability of granule cells (Jinde et al., 2012),
suggesting that mossy cells exert net inhibition on dentate
granule cells. In contrast, selective aspiration of mossy cells in
acute slices decreased field excitatory postsynaptic potential
amplitude in the dentate gyrus (Ratzliff et al., 2004), suggesting
net excitation exerted by mossy cells on granule cells. Our pre-
sent results with CSD analysis in the dentate gyrus and optoge-
netic excitation of mossy cell terminals in vivo support the latter
notion. The apparent controversy about the net effect of mossy
cells on the excitability of granule cells might be partly attribut-
able to high levels of DGLa expression in granule cells and
mossy cells with a virtual absence of DGLa in inhibitory interneu-
rons in the dentate gyrus (Uchigashima et al., 2011). Mossy cell
terminals on granule cells but not those on inhibitory interneu-
rons are considered to be suppressed by 2-AG released from
granule cells. Therefore, it may depend on the overall neural cir-
cuit activity and the extent of 2-AG signaling whethermossy cells
exert net excitation or inhibition on granule cells.
In the dentate gyrus, inhibitory terminals projecting onto
granule cells also express CB1 receptors (Uchigashima et al.,
2011). Because activation of CB1 receptors decreases the
GABAergic current in dentate granule cells (Isokawa and Alger,
2005), CB1 receptor signaling at inhibitory synapses is potentially
pro-epileptic. In accordance with this notion, conditional dele-
tion of CB1 receptors from inhibitory neurons increased the
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Figure 7. 2-Arachidonoylglycerol Signaling Suppresses Sponta-
neous Epileptic Seizures in the KA-Induced Chronic Seizure Model
(A) Basic experimental scheme. KA was injected to the right dentate gyrus of
8-week-old WT mice. Two weeks after KA injection, mice were treated with
JZL184 (4 mg/kg, i.p.) or AM251 (20 mg/kg, i.p.) once a day for 10 days.
Monitoring of seizures (6 hr/day) was started on day 2 of drug treatment and
continued for 9 days.
(B and C) Mean number of spontaneous seizures per mouse during the daily
monitoring period plotted for 9 consecutive days (B) and ensemble average
of the daily scores (C). The number inside each column in (C) represents
the number of mice examined. Error bars attached to individual columns
represent ± SEM. *p < 0.05 by Welch’s t test.afterdischarge duration by amygdala stimulation (von R€uden
et al., 2015b) or did not affect KA-induced seizures (Monory
et al., 2006). Therefore, the suppressive effect of endocannabi-
noid signaling on epileptic activity is indicated to be largely medi-
ated by CB1 receptor signaling at excitatory synapses.
As for the effect of cannabinoid signaling on epileptogenesis,
conflicting results have been reported (Chen et al., 2007; Ma
et al., 2014). Blockade of 2-AG synthesis or CB1 receptors imme-
diately after the initial insult prevents epileptogenesis in status
epilepticus (Ma et al., 2014) or the hyperthermia-induced seizure
model (Chen et al., 2007). In these models, initial spontaneous
seizures are so strong that animals often die. Such severe insultsare thought to accompany intense activation of endocannabi-
noid signaling and may result in the downregulation of CB1
receptors in the excitatory terminals (Falenski et al., 2009). The
blockade of CB1 receptors during the initial insult may prevent
their downregulation and preserve their function, which may
eventually prevent epileptogenesis. In the present study, DGLa
KO mice exhibited significantly faster kindling development
compared with WT littermates. Furthermore, pharmacological
blockade of CB1 and CB2 receptors also promoted kindling epi-
leptogenesis. These results clearly show that the lack of 2-AG
signaling throughout the process of kindling promotes epilepto-
genesis. We also found that after epileptogenesis, inhibition of
2-AG hydrolysis effectively suppressed, whereas blockade of
the CB1 receptor increased, the occurrence of spontaneous
seizures. These results strongly suggest that 2-AG signaling is
essential for the suppression of seizures in epileptic brains and
that enhancement of 2-AG signaling may be a promising way
to treat epilepsy.
EXPERIMENTAL PROCEDURES
Full details of experimental procedures are described in the Supplemental
Information.
Animals
Two- to 4-month-old male and female C57BL/6N mice, DGLa KO mice (Tani-
mura et al., 2010), CB1 KO mice (Figure S1), and their WT littermates were
used. Animals were housed in a plastic cage in a room illuminated with a 12-
hr-light/12-hr-dark cycle and fed with standard mouse chow and water ad
libitum. All procedures involving animal care were approved by the University
of Tokyo Animal Care and Use Committee.
KA-Induced Seizures
Mice were treated with drugs (AM251, AM630, and JZL184) or vehicle 60 min
before the injection of KA (30 mg/kg dissolved in saline, i.p., Tocris). After the
injection of KA, latency to GTCS was determined in each animal by an exper-
imenter blind to the drug treatment and genotype.
Induction of Afterdischarges in the Dentate Gyrus of Anesthetized
Mice
In WT mice, drugs (AM251 or AM251+AM630) or vehicle was administered
after setting the electrodes. Afterdischarges were induced by a 10-s stimulus
train composed of 500-ms square pulses at 20 Hz. The stimulus intensity was
initially set at 50 mA. The stimulus train was applied at 1-min intervals with stim-
ulus strength increasing by steps of 50 mA until afterdischarges were detected
in the LFPs.
Whole-Cell Recordings from Dentate Granule Cells In Vivo
The method for whole-cell recording from dentate granule cells in vivo was the
same as that described previously (Sugaya et al., 2013). After recording resting
membrane potential, burst stimuli were applied to the perforant path and
evoked dentate afterdischarges as described above.
Optogenetic Inhibition of Granule Cells
AAV1-CaMKII-ArchT-GFP (Vectorcore) was injected into the bilateral dentate
gyrus of 2- to 4-month-old DGLa KO mice or into the right dentate gyrus of
8-week-old C57BL/6N mice. Four weeks after the injection, afterdischarges
were induced more than five times, alternately without and with optogenetic
inhibition.
Optogenetic Activation of Mossy Cell Axon Terminals
AAV2-CAGGS-ChRWR/Venus was injected into the right dentate gyrus of
8-week-old C57BL/6N mice. Four weeks after the injection, dentate afterdi-
scharges were induced five times by perforant path stimulation as describedCell Reports 16, 1405–1415, August 2, 2016 1413
above. On the second and fourth trials of afterdischarge induction, optoge-
netic stimulation (50-ms pulse stimuli at 10 Hz) of mossy cell axons was per-
formed 50 ms after the end of burst stimulation of the perforant path.
Perforant Path Kindling Protocol
One week after the implantation of electrodes, afterdischarges were induced
twice daily with an interval of more than 6 hr while the mice were exploring
freely in their cages. Drugs (JZL184, AM251, AM630, and AM251+AM630) or
vehicle were injected 3 hr before the first kindling stimulus of the day. Behav-
ioral seizures were rated according to Racine’s seizure rating scale (Racine,
1972). Animals were judged to be fully kindled when three consecutive sei-
zures of class V or greater were observed.
Monitoring Spontaneous Seizures after KA-Induced Status
Epilepticus
KA (0.2 mg in 100 nl saline, 50 nl/min) was injected into the right dentate gyrus of
8-week-old C57BL/6N mice under isoflurane anesthesia (1.5%). Fourteen
days after the KA injection, JZL184, AM251, or vehicle was injected once a
day for 10 consecutive days. From day 2, the occurrence of spontaneous sei-
zures was monitored for 6 hr per day for 9 consecutive days. For the immuno-
histochemical analysis of DGLa and CB1 receptors, a different set of mice in-
jected with KA was used.
Statistics
All data were expressed as mean ± SEM, and statistical information of each
test is indicated. Datasets with normal distributions were analyzed with un-
paired two-tailed Welch’s t test or one-way ANOVA. Datasets with non-
Gaussian distributions were analyzed with the Mann-Whitney U test.
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